期刊文献+

乳腺癌临床病理特征研究

Clinic of Pathological Features of Breast Cancer Research
下载PDF
导出
摘要 目的:研究乳腺癌患者的病理特征。方法:回顾性分析我院收治的100例患者的临床病例资料,探讨其临床病理特征,为早诊断提供依据。结果:乳腺癌患者临床发病率最高的年龄段在41—50岁,其次是51—60岁,肿块好发部位位于外上象限32例,以非浸润性居多,雌激素受体(ER)阳性45例,孕激素受体(PR)阳性42例,人表皮生长因子受体2(HER-2)13例。结论:旱发现,早诊断乳腺癌,做好治疗及对症处理,是提高乳腺癌惠者生存率的关键。 Objective: To study the pathological characteristics of breast cancer patients. Methods: In our hospital were retrospectively analyzed clinical data of 100 patients, to explore the clinical pathological characteristics, provide the basis for early diagnosis. Results: Breast cancer clinical incidence was the highest in 41 to 50 years of age, and the second is 51 to 60 years old, quadrant goes up outside bump good hair place is located in 32 cases, in the majority with non invasive, estrogen receptor (ER) - positive 45 cases, progesterone receptor (PR) positive cases, 42 people epidermal growth factor receptor 2 (2) its ehrs a 13 cases. Conclusion:Early detection, early diagnosis of breast cancer, treatment and symptomatic treatment, is the key to improve survival of patients with breast cancer.
作者 赵虹
出处 《中国伤残医学》 2013年第9期58-59,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 乳腺癌 病理特征 诊断 Breast cancer Pathological features Diagnosis
  • 相关文献

参考文献3

二级参考文献17

  • 1杨文涛,张廷璆,沈铭昌,袁亚.乳腺腺样囊性癌临床病理特点及文献复习[J].临床与实验病理学杂志,2005,21(1):10-13. 被引量:28
  • 2[2]Acs G,Simpson JF,Bleiweiss IJ,et al.Microglandular adenosis with transition into adenoid cystic carcinoma of the breast[J].Am J Surg Pathol,2003,27(8):1052-1060.
  • 3[3]Arpino G,Clark GM,Mohsin S,et al.Adenoid cystic carcinoma of the breast:molecular markers,treatment,and clinical outcome[J].Cancer,2002,94(8):2119-2127.
  • 4[4]Tavassoli FA,Devilee P.World Health Organization Classification of Tumours:Pathology and genetics of tumours of the breast and female genital organs[M].Lyon:IARC Press,2003:44-45.
  • 5Crivellari D, Pagani O, Veronesi A, et al. International breast cancer study group. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel[J]. Ann Oncol,2001,12:353 - 356.
  • 6Abali H, Celik I. High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and doeetaxel[J]. Am J Clin Oncol,2002,25: 632 - 633.
  • 7Chang J, Clark GM, AUred DC, et al. Survival of patients with metastatic breast carcinoma:importance of prognostic markers of theprimary tumor[J]. Cancer,2003,97:545- 553.
  • 8Engel J,Eckel R,Aydemir U,et al. Detenninants and prognoses of locoregional and distant progression in breast cancer[J]. Int J Radiat Oncol Biol Phys, 2003, 55 :1186 - 1195.
  • 9Samanan NA, Buzdar AU,Aldinger KA, et al. Estrogen receptor: a prognostic factor in breast cancer[ J ]. Cancer, 1981,47:554 - 560.
  • 10Stewart JF,King RJ,Sexton SA,et al. Oestrogen receptors, sites of metastatic disease and survival in recmTent breast cancer[J]. Eur J Cancer, 1981,17:449 -453.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部